Sonepcizumab Antibody
Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. It is utilized in oncology research, particularly for studying metastatic renal cell carcinoma, and in ophthalmic research to inhibit post-surgical scarring. Its applications are supported by investigations in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
LPL Receptor, LPLReceptor, LT 1009, LT1009, LT-1009, Sonepcizumab
Target
LPL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Pharmacology & Drug Discovery
Concentration
7.43 mg/mL
Purity
98.90% (May vary between batches)
Molecular Weight
146.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
